Ethan Jameson

While freelancing with Hill Holliday Health, I also worked on a Xarelto project writing copy for a core component of the CV Health Risk Tool - the PAD (Peripheral Artery Disease) webpage. The strategy was to not only further inform and educate consumers about the disease, but also what this particular treatment could do to help.

Want to read through the website PDF? Download it here.

Xarelto, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.

Agency: Hill Holliday Health